Mission
Our mission is to empower healthcare business owners by providing comprehensive and strategic succession planning solutions, ensuring a smooth and seamless transition for family-owned practices and polyclinics. By consolidating these businesses, we aim to create a unified, world-class healthcare group that elevates the standard of care across the UK and the Emerald Isle.
We are dedicated to fostering growth and innovation while preserving the legacy of individual healthcare providers. Through our expertise in mergers and acquisitions, operational excellence, and financial optimization, we deliver substantial financial value and long-term sustainability for business owners and stakeholders.
Quantum Medix envisions a future where patients benefit from cutting-edge medical services, supported by an integrated network of healthcare providers driven by a shared commitment to excellence. Join us on this transformative journey to redefine healthcare and unlock the full potential of your business. Schedule an appointment today to explore the possibilities.independence and achieve their health and wellness goals.
About US
Quantum Medix is a pioneering investment consortium on a transformative mission to revolutionise healthcare across the UK & Ireland. By strategically acquiring and consolidating specialised health clinics and dental practices, Quantum Medix is set to redefine the healthcare landscape, ensuring unparalleled access to cutting-edge medical services for millions. Join us as we embark on this monumental journey to shape the future of healthcare in these regions.
With expertise spanning Healthcare C-suite Management, M&A transactions, Corporate Law, Corporate Finance, IPOs, and Entrepreneurial Leadership, our team brings together a formidable 200+ years of combined business experience.
Founding director
Antonia O'Hanlon
Antonia is the visionary founder of Quantum Medix, a pioneering investment consortium reshaping the healthcare landscape across the UK and Ireland. The firm specializes in acquiring and consolidating specialized health clinics and dental practices, enabling millions of people to access cutting-edge medical services. With over 15 years of experience as a senior leader in the software industry, Antonia brings a strategic, data-driven mindset and exceptional operational expertise to propel Quantum Medix’s mission of delivering growth and innovation in healthcare.
Antonia oversees critical areas including investment sourcing, deal structuring, acquisition financing, and strategic growth. Her distinctive blend of technical and executive acumen positions Quantum Medix as a leader in healthcare innovation. The company provides healthcare providers with capital, operational support, and access to expansive networks, driving sustainable growth while mitigating risks.
Under her leadership, Quantum Medix combines deep expertise in healthcare management, mergers and acquisitions, and corporate finance with a commitment to innovation. This approach ensures a seamless transition for businesses through tailored succession planning and optimized deal structures, offering sellers the best path to a successful exit. Quantum Medix stands at the forefront of healthcare transformation, with an outstanding team that empowers businesses to thrive in an evolving industry.
meet the board
Chairman
Jonathan Wogel
Jonathan has over 35 years' global blue chip pharma/healthcare corporate strategy, M&A, JV licensing, and scale up experience in the UK, USA, AsiaPac and Middle East. He has developed over £8bn in M&A deals for private and PE backed businesses and launched/licenced over 50 products globally. More recently, Jonathan has focused on helping SMEs and start-ups with seed/Series A, B and Angel/PE based fundraising by developing and implementing business and commercial strategies to drive scale. He has a BSc in Biochemistry and advanced degrees in business administration, public health, and health economics.
Jonathan is CEO and a board member of NorthWest EHealth, a tech enabled clinical trials company, NED & director of Zentraxa, a biomaterials spin out from the University of Bristol, and trustee of Active Cheshire.
Chief Financial Officer
Phil Branston
A seasoned finance and strategy leader in technology and e-commerce businesses, with experience in public, VC-backed and PE-backed companies of various sizes.
Phil is an experienced CFO and Finance Director, taking finance process, commercial governance, budgeting and funding to the next level in growing businesses.
He has a long M & A transaction history, having led on origination, diligence, negotiation and post-deal integration on over £1 billion worth of deals.
Equity raises, venture debt funding, credit facilities, inventory finance and equipment finance are the funding lines that Phil has secured, covering over £400m in total and leading on key phases of the funding cycle such as investor outreach, diligence, and negotiating terms.
Phil has, on a number of occasions, entered companies and created strategy teams from scratch as well as the analysis, decision-making and change programmes needed to evolve strategy.
coming soon.....